Overview
Status
Active
Registry date
2017-07-25
Share capital
5,000.00 PLN
Financials
This entity has not filed any financial documents with the Financial Document Repository (RDF).
Industry
Authorized Representatives
Jacek Wiesław Gorczykowski – President of the Management Board
Manner of representation
In the case of a management board consisting of two or more persons – joint action by two members of the management board or by one member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Jacek Wiesław Gorczykowskiage 58 | 99 | $1,337.12 | 99% |
Others | 1 | $13.51 | 1% |
Beneficial owners
No beneficial owners recorded for the company Willo Pharma.
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| Natur DayS.A. | $680,635.59 | naturday.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Nature's Voicesp. z o.o. | $181,977.76 | naturesvoice.eu | ||
| Pexon Polandsp. z o.o. | $122,615.96 | pexon.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Grupa FinepharmS.A. | – | finepharm.pl |
FAQ
The main business activity of Willo Pharma focuses on manufacture of basic pharmaceutical products.
The company was registered in the Polish National Court Register (KRS) on July 25, 2017.
The headquarters is located at: ul. Smolna 40, 00-375 Warszawa.
The management board consists of: Jacek Wiesław Gorczykowski (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
Last updated: 2026-04-24